Promising medical therapies for Parkinson's disease [electronic resource] / Robert A. Hauser.
Material type:
FilmSeries: Henry Stewart talksBiomedical & life sciences collection. Parkinson's disease: Publisher: London : Henry Stewart Talks, 2014Description: 1 online resource (1 streaming video file (41 min.) : color, sound)Subject(s): Antiparkinsonian agents -- Side effects | Antiparkinsonian agents | Dopa -- Physiological effect | Parkinson's disease -- Chemotherapy | Parkinson's disease -- Treatment | Adenosine A2 Receptor Antagonists | Antiparkinson Agents -- adverse effects | Antiparkinson Agents -- therapeutic use | Apomorphine -- pharmacokinetics | Benzylamines -- pharmacokinetics | Dopamine Agonists | Dyskinesia, Drug-Induced -- prevention & control | Levodopa -- therapeutic use | Parkinson Disease -- drug therapy | Parkinson Disease -- therapy | Receptor, Metabotropic Glutamate 5 -- antagonists & inhibitorsOnline resources: Click here to access online | Series Animated audio-visual presentation with synchronized narration.
Title from title frames.
Contents: Selected Future Therapies for Motor Fluctuations and Dyskinesias -- Ankiparkinsonian agents -- A2a antagonists -- Levodopa preparations -- VR040 (inhaled apomorphine) -- Safinamide (mixed MOA : MAO-B and glu inhibition) -- Anti-dyskinetics -- AFQ056 : mGluR5 antagonist -- ADX48621 (dipraglurant) : mGluR5 negative allosteric modulator -- Fipamezole :a2 adrengergic receptor antagonist -- ADS-5102 : sustained release amantadine.
Access restricted to subscribers.
Mode of access: World Wide Web.